- Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomesGerardus W J Frederix
Department of Clinical Pharmacology and Experimental Therapy, The Netherlands
Value Health 15:94-105. 2012..A secondary objective is to identify whether differences in seven modeling characteristics are related to differences in outcome of these cost-effectiveness and cost-utility analyses...
- Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in RGerardus W J Frederix
Department of Clinical Pharmacology and Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Med Decis Making 33:780-92. 2013....